IL15 and Kaposi's sarcoma: However, across the clinical follow-up, KS/HIV patients with CT decreased IL-15 levels at W4 compared to W0 (p = 0.0020), whereas those KS/HIV patients that received MT decreased IL-15 level until the W12 compared to W0 (p = 0.0030) (Figure 4).